Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bo Xiang

Showing results (351-360 of 576) with videos related to

Pageof 58
Sort By:
Plos One|August 8, 2014
A novel CDX2 isoform regulates alternative splicingMatthew E Witek, Adam E Snook, Jieru E Lin, et al.
Science Bulletin|April 26, 2026
Non-progressive orogenesis of the Southern Tibetan PlateauXiaoyu Guo, Hengcheng Ying, Lin Chen, et al.
Molecular Biosystems|September 22, 2012
New prognosis biomarkers identified by dynamic proteomic analysis of colorectal cancerYa Peng, Xiayu Li, Minghua Wu, et al.
Diagnostics (Basel, Switzerland)|November 13, 2025
Advancing Prostate Cancer Assessment: A Biparametric MRI (T2WI and DWI/ADC)-Based Radiomic Approach to Predict Tumor-Stroma RatioJiangqin Ma, Xiling Gu, Zhonglin Zhang, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|August 1, 2024
T cell exhaustion in human cancersKuan Kang, Xin Lin, Pan Chen, et al.
Journal of Affective Disorders|May 17, 2021
Sleep duration and auditory hallucinations: Genetic correlation and two-sample Mendelian randomization studyMinglan Yu, Yanhong Du, Kezhi Liu, et al.
Basic & Clinical Pharmacology & Toxicology|May 26, 2017
Safety, Pharmacokinetics and Pharmacodynamics of Hetrombopag Olamine, a Novel TPO-R Agonist, in Healthy IndividualsLi Zheng, Mao-Zhi Liang, Xiao-Ling Zeng, et al.
Zhong Nan Da Xue Xue Bao. Yi Xue Ban = Journal of Central South University. Medical Sciences|July 6, 2013
[MicroRNAs and nonresolving inflammation-related cancer]Zhaojian Gong, Shanshan Zhang, Ke Tang, et al.
Addictive Behaviors|October 18, 2020
Corrigendum to "The psychometric properties of the Chinese version internet gaming disorder scale" [Addictive Behaviors 106 (2020) 106392]Wei Lei, Kezhi Liu, Zhen Zeng, et al.
Cancer Letters|April 2, 2019
Corrigendum to 'High-affinity human programmed death-1 ligand-1 variant promotes redirected T cells to kill tumor cells' [Cancer Lett. 447 (2019) 164-173]Zhaoduan Liang, Yanyan Li, Ye Tian, et al.
Pageof 58

Showing results (351-360 of 576) with videos related to

Sort By:
Pageof 58
Plos One|August 8, 2014
A novel CDX2 isoform regulates alternative splicingMatthew E Witek, Adam E Snook, Jieru E Lin, et al.
Science Bulletin|April 26, 2026
Non-progressive orogenesis of the Southern Tibetan PlateauXiaoyu Guo, Hengcheng Ying, Lin Chen, et al.
Molecular Biosystems|September 22, 2012
New prognosis biomarkers identified by dynamic proteomic analysis of colorectal cancerYa Peng, Xiayu Li, Minghua Wu, et al.
Diagnostics (Basel, Switzerland)|November 13, 2025
Advancing Prostate Cancer Assessment: A Biparametric MRI (T2WI and DWI/ADC)-Based Radiomic Approach to Predict Tumor-Stroma RatioJiangqin Ma, Xiling Gu, Zhonglin Zhang, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|August 1, 2024
T cell exhaustion in human cancersKuan Kang, Xin Lin, Pan Chen, et al.
Journal of Affective Disorders|May 17, 2021
Sleep duration and auditory hallucinations: Genetic correlation and two-sample Mendelian randomization studyMinglan Yu, Yanhong Du, Kezhi Liu, et al.
Basic & Clinical Pharmacology & Toxicology|May 26, 2017
Safety, Pharmacokinetics and Pharmacodynamics of Hetrombopag Olamine, a Novel TPO-R Agonist, in Healthy IndividualsLi Zheng, Mao-Zhi Liang, Xiao-Ling Zeng, et al.
Zhong Nan Da Xue Xue Bao. Yi Xue Ban = Journal of Central South University. Medical Sciences|July 6, 2013
[MicroRNAs and nonresolving inflammation-related cancer]Zhaojian Gong, Shanshan Zhang, Ke Tang, et al.
Addictive Behaviors|October 18, 2020
Corrigendum to "The psychometric properties of the Chinese version internet gaming disorder scale" [Addictive Behaviors 106 (2020) 106392]Wei Lei, Kezhi Liu, Zhen Zeng, et al.
Cancer Letters|April 2, 2019
Corrigendum to 'High-affinity human programmed death-1 ligand-1 variant promotes redirected T cells to kill tumor cells' [Cancer Lett. 447 (2019) 164-173]Zhaoduan Liang, Yanyan Li, Ye Tian, et al.
Pageof 58